	Real-World Outcomes of Consolidation Durvalumab After Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Cohort Study From Vietnam. Asia Pac J Clin Oncol Tran HT, Do KH, Nguyen HTT, Nguyen HTN, Nguyen PTB, Dao TM, Van Nguyen T, Nguyen TA, Doan HN, Hoang NB. PMID: 42569796 [PubMed - as supplied by publisher]
	Prognostic and Predictive Value of Peripheral CD8/PD-1/TCF-1 Positive T Cells in Non-Small Cell Lung Carcinoma Patients. Immunotargets Ther Xagara A, Goulielmaki M, Chantzara E, Koinis F, Fortis SP, Hatzidaki D, Ntostoglou K, Christodoulopoulos G, Saloustros E, Karagiannis SN, Frisan T, Baxevanis CN, Georgoulias V, Pateras IS, Kotsakis A. PMID: 42569581 [PubMed]
	Metal Nanoparticles as Sensitizers in Energy-Based Therapies for Lung Cancer: From Mechanistic Insights to Clinical Translation. Int J Nanomedicine Jin X, Li Y, Zhang R, Yang Y, Han A, Jin X, Zhang S, Quan C, Lin Z, Lin X. PMID: 42569506 [PubMed - indexed for MEDLINE]
	The effect of motivational interviewing on smoking cessation intention in patients with lung cancer: A randomized controlled trial. Tob Induc Dis Dogru S, Aytaç S, Ovayolu Ö. PMID: 42569500 [PubMed]
	Application of an improved YOLOv5s-based deep learning model for automated detection of pulmonary adenocarcinoma in situ and minimally invasive adenocarcinoma. Front Med (Lausanne) Sun Z, Chen J, Xie L, Yang T, Yang L, Ye C, Zhao H. PMID: 42568391 [PubMed]
	Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation. Drugs Sindhwani S, Thomas M, Gehlaut K, Kaur H, Haque W, Juloori A, Choudhury NJ. PMID: 42568026 [PubMed - as supplied by publisher]
	Primary pulmonary presentation extranodal NK/T-cell lymphoma, small cell variant, illustrating the value of flow EBER in situ hybridisation assay. J Hematop Kale S, Rudzki Z, Maybury B, Selvapandian K, Langman G, Shannon-Lowe C. PMID: 42567998 [PubMed - indexed for MEDLINE]
	Scaling AI-enabled imaging-based screening: lessons from reporting for the NHS England lung cancer screening programme. Clin Radiol Hare SS, Robinson GRE, Tavare A, Head J, Selby I, Barnett J, Babar JL, Rodrigues JCL. PMID: 42567112 [PubMed - as supplied by publisher]
	DAFNet: A multi-modal deep learning model based on whole-lung CT for the automated prediction of the air space spread of lung adenocarcinoma. Lung Cancer Guo J, Qiu S, You H, Zhang H, Liang H, Wang P, Zhang Z, Meng W, Hu Y. PMID: 42566922 [PubMed - as supplied by publisher]
	A multimodal bronchoscopic approach for diagnosing peripheral ground-glass nodules using Cone-Beam computed tomography and cryobiopsy: a preliminary study. Ann Med Lin CK, Ruan SY, Fan HJ, Chang HC, Lin YT, Ho CC. PMID: 42566914 [PubMed - indexed for MEDLINE]
	Efficacy and safety of first-line immune checkpoint inhibitors combinations for extensive-stage small-cell lung cancer: A systematic review and network meta-analysis. Medicine (Baltimore) Ye X, Meng H, Guo Q, Liang X, Chen X, Li Y. PMID: 42566592 [PubMed - indexed for MEDLINE]
	Artificial Intelligence-Driven Multiomics Integration in Lung Cancer: From Data Convergence to Precision Phenomics. OMICS Dasgupta S, De D. PMID: 42566262 [PubMed - as supplied by publisher]
	Immunological biomarkers for precision stereotactic body radiation therapy in early-stage non-small cell lung cancer: a systematic review. EClinicalMedicine Volpe S, Lee S, Bilski M, Vincini MG, Onza M, Piperno G, Zerella MA, Cornacchia L, Palumbo L, Fulghieri P, Zappia A, Noberini R, Lombardi M, Mane E, Venetis K, Casiraghi M, Spaggiari L, Bonaldi T, Fusco N, Orecchia R, Jereczek-Fossa BA. PMID: 42564821 [PubMed]
	Radiomic and clinical predictors of epidermal growth factor receptor mutation in stage IA non-small cell lung cancer. PeerJ Guan W, Chen J, Zeng X, Chen Y, Liu B, Xin P, Huang Z, Chen W, Zheng Y, Chen J, Ren L, Ren D, Zhang X, Huang Y, Liu S. PMID: 42564746 [PubMed - indexed for MEDLINE]
	Integrated cellular, proteomic and metabolomic profiling of immune-related adverse events in non-small cell lung cancer. Front Immunol Smith NJ, Gunasegaran B, McLean A, Kohonen-Corish MRJ, Bucca A, Checkley J, Lee JH, Liu JJ, Kao S, Boyer M, Mander K, Brown B, Wang XS, O'Sullivan JF, Fazekas de St Groth B, McGuire HM. PMID: 42564206 [PubMed - indexed for MEDLINE]
	Microbiome as a prediction of immunotherapy response in lung cancer. Front Immunol Rojas L, Zuluaga J, Cardona AF. PMID: 42564172 [PubMed - indexed for MEDLINE]
	Editorial: Liquid biopsy in non-small cell lung cancer for diagnosis, treatment selection and monitoring. Front Oncol Strati A, Roch B, Sukari A. PMID: 42564141 [PubMed]
	Radiomics-based high-resolution CT analysis for differentiating primary tumor sources of pulmonary metastases. Front Oncol Liu K, Zhang Y, Xie X, Li N, Liu G, Li W, Wu Y, Hu B, Zhao F, Wan Z, Zhang Y, Zhou Y, Wu X. PMID: 42564115 [PubMed]
	Association between prognostic nutritional index and prognosis in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis. Front Nutr Li P, Wu Z, Chen H, Zhang H, Luo Z. PMID: 42564097 [PubMed]
	Cost-effectiveness analysis of combined immunotherapy regimens for non-squamous non-small lung cancer after tyrosine kinase inhibitors resistance. Front Public Health Teng M, Yang B, Zhang R, Qin F, Ji J. PMID: 42564047 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162113

Page 1 of 8106



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy